Dr Walley is Associate Professor of Medicine and an addiction expert at Boston Medical Center and Boston University School of Medicine. Dr Walley has conducted multiple studies related to the opioid crisis and the integration of addiction specialty care and general medical care. He has served as PI on a CDC-SAMHSA-Epi-AID investigation of the surge in fentanyl-related overdose, a CDC-funded study of the Massachusetts OEND program which demonstrated community-level reductions in overdose death rates, and a SAMHSA-funded program that integrated addiction treatment into the clinical care of people with/at risk for HIV. He has worked as Co-I with addiction, overdose, and HIV expertise on NIDA and NIAAA-funded clinical trials and cohort studies.
Dr Walley is the director of the Boston Medical Center Addiction Medicine Fellowship program, as well as the director the NIDA-funded Fellow Immersion Training program in Addiction Medicine, which trains 5 subspecialty fellows each year to integrate addiction science into their subspecialty research. He provides primary care and addiction medicine consultations in the HIV primary care clinic at Boston University School of Medicine/BMC where he leads the FAST PATH (Facilitated Access to Substance abuse Treatment for Prevention and Treatment of HIV) program. Dr Walley co-founded and provides care on the inpatient addiction consult service at Boston Medical Center, which regularly provides consultation for patients admitted to the hospital who use alcohol and substances. Lastly, Dr Walley has been the medical director of the Massachusetts Opioid Overdose Prevention program since it started in 2007. They have trained and equipped over 80,000 people in the community with naloxone rescue kits, culminating in over 19,000 documented overdose rescues.
- Courtesy Staff Privileges, Medicine, Boston Medical Center
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University School of Medicine
- Johns Hopkins University School of Medicine, MD
- Boston University School of Public Health, MSc
- Harvard College, AB
- Published on 3/18/2020
Green TC, Soipe A, Baloy B, Burstein D, Xuan Z, Tapper A, Walley AY, Case P, Bratberg J, Baird J. Pharmacy on-site overdose protocols and prevention of overdose. Subst Abus. 2020 Mar 18; 1-5. PMID: 32186478.
- Published on 3/2/2020
Kim TW, Ventura AS, Winter MR, Heeren TC, Holick MF, Walley AY, Bryant KJ, Saitz R. Alcohol and Bone Turnover Markers among People Living with HIV and Substance Use Disorder. Alcohol Clin Exp Res. 2020 Mar 02. PMID: 32124466.
- Published on 2/25/2020
Walley AY, Lodi S, Li Y, Bernson D, Babakhanlou-Chase H, Land T, Larochelle MR. Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis. Addiction. 2020 Feb 25. PMID: 32096908.
- Published on 1/18/2020
Donovan E, Bratberg J, Baird J, Burstein D, Case P, Walley AY, Green TC. Pharmacy leaders' beliefs about how pharmacies can support a sustainable approach to providing naloxone to the community. Res Social Adm Pharm. 2020 Jan 18. PMID: 31983625.
- Published on 1/8/2020
Park TW, Larochelle MR, Saitz R, Wang N, Bernson D, Walley AY. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine. Addiction. 2020 Jan 08. PMID: 31916306.
- Published on 12/20/2019
Burstein D, Baird J, Bratberg J, Donovan E, Soipe A, Tapper A, Case P, Walley AY, Green TC. Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study. J Am Pharm Assoc (2003). 2019 Dec 20. PMID: 31870862.
- Published on 11/15/2019
Green TC, Bratberg J, Baird J, Burstein D, Lenz K, Case P, Walley AY, Xuan Z. Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy. Int J Drug Policy. 2019 Nov 15; 102602. PMID: 31740174.
- Published on 11/5/2019
Thakarar K, Walley AY, Heeren TC, Winter MR, Ventura AS, Sullivan M, Drainoni M, Saitz R. Medication for addiction treatment and acute care utilization in HIV-positive adults with substance use disorders. AIDS Care. 2019 Nov 05; 1-5. PMID: 31686528.
- Published on 10/23/2019
Taylor JL, Walley AY, Bazzi AR. Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs. Subst Abus. 2019; 40(4):441-443. PMID: 31644387.
- Published on 10/10/2019
Kimmel SD, Walley AY, Linas BP, Kalesan B, Awtry E, Dobrilovic N, White L, LaRochelle M. Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug- and Non-Injection Drug-Associated Endocarditis. Clin Infect Dis. 2019 Oct 10. PMID: 31598642.
View 111 more publications: View full profile at BUMC